Results
1486
Companies which are more than 50% undervalued based on analyst price target.
1,486 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BENF | US$0.38 | -10.0% | -95.6% | US$3.5m | US$4.00 | PE-0.2x | E-111.9% | n/a | Diversified Financials | ||
ARTL | US$1.00 | -10.7% | -32.9% | US$3.5m | US$5.33 | PB0.5x | E40.0% | n/a | Pharmaceuticals & Biotech | ||
ACON | US$7.60 | 63.1% | -94.8% | US$3.4m | US$435.50 | PS156.6x | E7.5% | n/a | Healthcare | ||
PAPL | US$0.35 | -10.1% | -76.3% | US$3.3m | US$5.00 | PS1.1x | E31.6% | n/a | Diversified Financials | ||
GNPX | US$0.35 | -10.8% | -91.8% | US$3.2m | US$7.50 | PB1.8x | E-16.3% | n/a | Pharmaceuticals & Biotech | ||
BTTR | US$1.53 | -13.1% | -79.4% | US$3.0m | US$10.00 | PS0.08x | E180.8% | n/a | Food, Beverage & Tobacco | ||
SNES | US$2.92 | -6.4% | -66.2% | US$3.0m | US$10.00 | PS1.8x | E17.3% | n/a | Pharmaceuticals & Biotech | ||
PRSO | US$0.77 | -13.5% | -56.0% | US$3.0m | US$3.35 | PS0.2x | E56.0% | n/a | Semiconductors | ||
VTAK | US$0.32 | -10.8% | -94.1% | US$2.8m | US$2.00 | PS6.4x | E20.4% | n/a | Healthcare | ||
CNSP | US$2.20 | -23.6% | -99.8% | US$2.8m | US$112.50 | PB0.8x | E50.2% | n/a | Pharmaceuticals & Biotech | ||
THAR | US$1.45 | -14.2% | -74.6% | US$2.8m | US$5.00 | PB0.9x | E-23.1% | n/a | Pharmaceuticals & Biotech | ||
AWH | US$0.17 | -26.9% | -95.8% | US$2.8m | US$5.50 | PS0.3x | S56.6% | n/a | Healthcare | ||
SXTP | US$1.70 | -19.8% | -90.2% | US$2.7m | US$17.00 | PS5.4x | E-2.0% | n/a | Pharmaceuticals & Biotech | ||
NAYA | US$0.37 | -6.8% | n/a | US$2.6m | US$2.00 | PE-0.2x | E-33.1% | n/a | Healthcare | ||
PCSA | US$0.49 | -11.7% | -80.4% | US$2.6m | US$6.00 | PB0.6x | E-5.7% | n/a | Pharmaceuticals & Biotech | ||
YCBD | US$0.37 | -13.3% | -46.5% | US$2.5m | US$2.00 | PS0.1x | E95.3% | n/a | Pharmaceuticals & Biotech | ||
VINC | US$0.76 | -33.3% | -99.3% | US$2.4m | US$120.00 | PB0.2x | E-0.3% | n/a | Pharmaceuticals & Biotech | ||
XPON | US$1.06 | -22.1% | -99.7% | US$2.4m | US$4.00 | PS0.5x | E75.7% | n/a | Capital Goods | ||
NDRA | US$4.15 | -14.3% | -99.8% | US$2.3m | US$2,625.00 | PB0.3x | E-16.8% | n/a | Healthcare | ||
ICON | US$0.14 | -41.9% | n/a | US$2.3m | US$1.25 | PE3.5x | S49.0% | 237.8% | Transportation | ||
PALI | US$0.83 | -12.6% | -86.1% | US$2.3m | US$20.00 | PB0.3x | E-30.8% | n/a | Pharmaceuticals & Biotech | ||
BDRX | US$2.95 | -16.9% | -90.9% | US$2.2m | US$18.05 | PS18.7x | S-97.7% | n/a | Pharmaceuticals & Biotech | ||
BBLG | US$0.82 | -15.3% | -66.7% | US$2.2m | US$16.50 | PB0.6x | E34.6% | n/a | Pharmaceuticals & Biotech | ||
ATXI | US$1.01 | -22.4% | -91.5% | US$2.1m | US$8.00 | PB0.7x | E46.2% | n/a | Pharmaceuticals & Biotech |